The Seattle case, the first to reach trial in the U.S., offers possible glimpse into fate of some two dozen lawsuits against manufacturing giant Olympus, accused of failing to address scope contamination linked to numerous deaths. The company faults poor hospital cleaning practices.
Lo primero que hizo María Ríos cuando nació su beba es chequear el tamaño de su cabeza. Fue entonces cuando supo que sus miedos se habían hecho realidad: la niña había nacido con microcefalia, una consecuencia del zika.
So far, 72 affected babies have been born in the continental U.S. One young mother, infected in Mexico last year, and her infant face an uncertain future in rural Washington.
With the most expensive medical care and health insurance premiums in the nation, Alaska seeks a novel way to bail out Obamacare.
A state with integrated systems for end-of-life care offers better treatment for the seriously ill, according to a new study.
Some terminal patients, typically high-dose opioid users, who choose to end their lives have taken many hours, even days, to die.
The federal program paid $16 million in the first six months of 2016 to counsel 223,000 patients about treatment preferences in their last days.
In California, Colorado and four other states, many hospitals, health systems and doctors just say no.
Seattle seniors at an upscale assisted living center lament Washington’s rush to repeal and replace Obamacare with no alternative on the table.
A Seattle program pioneers palliative care that reaches dying patients on streets and in shelters.
Un nuevo estudio realizado por investigadores de la Universidad de Torino, en el noroeste de Italia, sugiere que no se deberían excluir los órganos de los adultos mayores sólo por la edad.
Investigators claim drugmaker employees met in secret at restaurants, golf outings and at “Girls Night Out” to raise generic drug prices.
Advocates want alternatives to drugmaker’s pricey pills for those who choose to die in Colorado and elsewhere.
Organs from elderly deceased donors can work for years, says a new study that supports growing views among U.S. transplant experts.